Similar articles

• [Glucocorticoids].

  Gromnica-Ihle E. Gromnica-Ihle E. Z Rheumatol. 2016 Aug;75(6):591-4. doi: 10.1007/s00393-016-0115-1. Z Rheumatol. 2016. PMID: 27412667 Review. German. No abstract available.
• A review of methotrexate-associated hepatotoxicity.

  Bath RK, Brar NK, Forouhar FA, Wu GY. Bath RK, et al. J Dig Dis. 2014 Oct;15(10):517-24. doi: 10.1111/1751-2980.12184. J Dig Dis. 2014. PMID: 25139707 Review.
• [Update on kinase inhibitors].

  Alten R. Alten R. Z Rheumatol. 2016 Aug;75(6):611-5. doi: 10.1007/s00393-016-0113-3. Z Rheumatol. 2016. PMID: 27365023 Review. German. No abstract available.
• Monitoring methotrexate hepatic toxicity in rheumatoid arthritis: is it time to update the guidelines?

  Yazici Y, Erkan D, Paget SA. Yazici Y, et al. J Rheumatol. 2002 Aug;29(8):1586-9. J Rheumatol. 2002. PMID: 12180713 Review. No abstract available.
• Complications with low dose methotrexate in rheumatoid arthritis.

  Kalke S, Balakrishnan C, Mittal G, Mangat G, Joshi VR. Kalke S, et al. J Assoc Physicians India. 1997 Nov;45(11):903-4. J Assoc Physicians India. 1997. PMID: 11229210 No abstract available.